GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk Ruchika Sharma11 Nov 2024 1:00 PM ISTMississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada for the prevention of...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report Farhat Nasim14 Oct 2024 5:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...
DCGI bans this popular anti-cold FDC for children under 4 Farhat Nasim14 Oct 2024 4:25 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...
GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits Ruchika Sharma10 Oct 2024 6:17 PM ISTNew York: Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S. state courts,...
Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine Ruchika Sharma9 Oct 2024 2:33 PM ISTLondon: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER Ruchika Sharma3 Oct 2024 1:33 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
OPPI appoints Bhushan Akshikar as President Ruchika Sharma27 Sept 2024 12:25 PM ISTMumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in...
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials MD Bureau Team13 Sept 2024 2:56 PM ISTBritish drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the...
GSK announces positive results from phase III trial of Nucala in COPD Ruchika Sharma8 Sept 2024 1:30 PM ISTLondon: GSK plc has announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) a...
GSK Nucala approved in Japan for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2024 4:19 PM ISTGSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Nucala (mepolizumab), a monoclonal antibody that...
